Post: Probiotics, Poor Diet May Interfere with Cancer Immunotherapy
Probiotic supplements and certain foods could affect how well people respond to cancer immunotherapy, due to the way they influence the...
11-20 of 573
Post: Researcher comment: The impact of lifestyle factors on the gut microbiome and immunotherapy response
Christine Spencer outlines her study investigating the effect of diet and supplements on gut microbiota and response to anti-PD-1 therapy in...
Post: Probiotics Linked to Poorer Response to Cancer Immunotherapy in Skin Cancer Patients
Study to be presented by Parker Institute researchers at AACR 2019 also finds eating fiber tied to better outcomes In...
Post: Despite research boom, few immunotherapy studies targeting pancreatic cancer
Dive Brief: Among the more than 2,600 clinical trials testing the most successful type of cancer immunotherapy, only 89, or about...
Post: AACR: Apexigen, BMS steal the show with promising I-O combo in pancreatic cancer
Last August, tiny California biotech Apexigen revved up its pipeline with a $73 million venture roundthat allowed it to move its lead...
Post: Immunotherapy, chemotherapy combination shows promising antitumor activity in metastatic pancreatic cancer
ATLANTA — The combination of the experimental CD40 antibody APX005M with nivolumab and standard chemotherapy demonstrated a manageable safety profile and...
Post: New pancreatic cancer drug regimen shows ‘impressive’ results in clinical trial
The Parker Institute for Cancer Immunotherapy, funded by Napster founder and billionaire Sean Parker, on Sunday presented the results of clinical...
Post: The Parker Institute touts early results in pancreatic cancer trial — and a new model to accelerate drug development
Silicon Valley billionaire Sean Parker — the founder of Napster and an early investor in Facebook — pledged $250 million in...